NCT00657514: Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease |
|
|
| Withdrawn | 4 | 0 | US | Ranolazine, Ranexa, extended-release tablets, CVT500, light orange, NDC Code: 67159-112-04, Placebo | Colorado Prevention Center | Peripheral Arterial Disease, Angina | 06/09 | 06/09 | | |
